Immune enhancement and disease resistance againstinfection by dietary-fermentedleaves in.

Abstract

For enhancing the nutritional characteristics ofleaves (MOLs), the present research set out to examine the effect of MOLs fermented by(MOLF) or MOLs powder (MOLP) on innate immunity defense and resilience tochallenge in. A 30-day experiment was conducted with 180 Nile tilapia fingerlings, divided randomly into five equal-sized groups of 36 fingerlings, three replicates per group. The 1st control fish received a basal meal devoid of any supplements. The 2nd MOLP-L and the 3rd MOLP-H fish received basal meals enriched with low and high levels of MOLP (50 g or 100 g/kg diet). The 4th MOLF-L and 5th MOLF-H fish received basal meals enriched with low and high levels of MOLF (50 g or 100 g/kg diet). Ferulic acid, gallic acid, caffeic acid, and p-coumaric acid were the primary phenolic components identified by HPLC in the fermented MOLs. Meanwhile, naringenin, rutin, quercetin, kaempferol, luteolin, apigenin, and catechin were the main flavonoids detected. The results revealed that MOLF dietary supplementation enhanced the immune-related outcomes more significantly (< 0.05) than MOLP in a dose-related manner. Supplementation of MOLF increased serum nitric oxide and lysozyme levels, phagocytic index, phagocytic %, hepatic superoxide dismutase, and glutathione, yet declined the levels of malondialdehyde more significantly (< 0.05) than the MOLP. The proinflammatory genes&#x3b2;,&#x3b1;, andwere significantly (< 0.0.05) down-regulated. In contrast, the expression of thegene was markedly upregulated in the spleen and head kidney (anterior) postchallenge in the MOLF-groups than the MOLP-groups. MOLF-supplemented groups showed a significantly (< 0.05) enhanced relative proportion of survivorship and survival rates but decreased thebacterial load (CFU) compared to the MOLP-supplemented groups. In conclusion, our findings have offered new insights into the promising immune-enhancing outcome of MOLF as a dietary supplement for immune augmentation against disease challenges in Nile tilapia.